ZA200704794B - Treatment of an instestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation - Google Patents

Treatment of an instestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation

Info

Publication number
ZA200704794B
ZA200704794B ZA200704794A ZA200704794A ZA200704794B ZA 200704794 B ZA200704794 B ZA 200704794B ZA 200704794 A ZA200704794 A ZA 200704794A ZA 200704794 A ZA200704794 A ZA 200704794A ZA 200704794 B ZA200704794 B ZA 200704794B
Authority
ZA
South Africa
Prior art keywords
instestinal
adenoma
adenocarcinoma
inhibition
treatment
Prior art date
Application number
ZA200704794A
Inventor
Clevers Johannes Carolus
Van Gijn Maria Elisabeth
Van Es Johannes Hendrikus
Original Assignee
Hubrecht Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubrecht Lab filed Critical Hubrecht Lab
Publication of ZA200704794B publication Critical patent/ZA200704794B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
ZA200704794A 2004-11-10 2005-11-10 Treatment of an instestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation ZA200704794B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04078090 2004-11-10

Publications (1)

Publication Number Publication Date
ZA200704794B true ZA200704794B (en) 2008-09-25

Family

ID=34928648

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704794A ZA200704794B (en) 2004-11-10 2005-11-10 Treatment of an instestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation

Country Status (2)

Country Link
CN (1) CN101098708A (en)
ZA (1) ZA200704794B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266587B (en) * 2011-07-20 2013-12-04 山东省眼科研究所 Preparation method of recombinant eye conjunctival epithelial diaphragm containing goblet cells
KR20170029490A (en) * 2014-07-11 2017-03-15 제넨테크, 인크. Notch pathway inhibition
CN107349193A (en) * 2016-05-10 2017-11-17 北京市神经外科研究所 Purposes of the protein function inhibitor DAPT in the medicine for preparing treatment endocrine system disease
CN107349414A (en) * 2016-05-10 2017-11-17 北京市神经外科研究所 Purposes of the protein function inhibitor DAPT in the medicine for preparing treatment tumour

Also Published As

Publication number Publication date
CN101098708A (en) 2008-01-02

Similar Documents

Publication Publication Date Title
IL183031A0 (en) Traetment of intestinal adenoma and/or adeocarcinoma by inhibition of notch pathway activation
EP1737386A4 (en) Methods of treatment with syk inhibitors
SG152225A1 (en) Inhibitors of iap
IL179854A0 (en) Inhibitors of iap
ZA200704909B (en) Method of treatment or prophylaxis
EP1838714A4 (en) Methods of treating pain
EP1692085A4 (en) Inhibition of fgfr3 and treatment of multiple myeloma
EP2063882A4 (en) Tyrosine kinase inhibitors for prevention or treatment of infection
EP1729761A4 (en) Cadasil treatment with cholinesterase inhibitors
EP1901835A4 (en) Monopersulfate treatment of membranes
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1829566A4 (en) Biofilm formation inhibitor and treatment device
EP2046489A4 (en) Improved monopersulfate treatment of membranes
GB0616670D0 (en) Polycarbosilane treatment of substrates
ZA200704794B (en) Treatment of an instestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation
ZA200610736B (en) Treatment of hydrocarbons
EP1771203A4 (en) Inhibition of nf-kb
EP1742671A4 (en) Electric field fluid treatment chamber
GB0426196D0 (en) Methods of treatment
GB0410502D0 (en) Treatment of metakaolin
EP1601353A4 (en) Prevention of surgical adhesions using selective cox-2 inhibitors
EP1976976A4 (en) Treatment of neuroaids using inhibitors of glycogen synthase kinase (gsk)-3
GB0503540D0 (en) Inhibition or treatment of dyskinesia
GB0508843D0 (en) Inhibition or treatment of dyskinesia
HU0400952D0 (en) Treatment of anus-cancer